About Via Science
Via Science is a private company based in Somerville, Massachusetts. It has reported $51,177,706 raised in six offerings on Form D since December 2016. Its chief executive is Colin Gounden.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 23, 2025 | Mar 4, 2025 | $28,393,347fully sold | 13 | $2.1M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 8, 2021 | Mar 19, 2021amended Feb 18, 2022 | $10,075,932of $12.7M target | 7 | $1.4M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 31, 2019 | Mar 31, 2020amended Apr 29, 2020 | $2,600,000of $3.0M target | 3 | $866K | Equity, DebtRule 506(b) | Form D/A ↗1 earlier filing |
| May 30, 2019 | Jun 13, 2019 | $6,323,427of $7.0M target | 3 | $2.1M | Equity, OptionsRule 506(b) | Form D ↗ |
| Nov 9, 2017 | Mar 26, 2019 | $3,285,000of $5.0M target | 13 | $252K | Debt, Securities on exercise, Convertible promissory notesRule 506(b) | Form D ↗ |
| Nov 29, 2016 | Dec 14, 2016 | $500,000of $3.0M target | 1 | $500K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, six offerings | $51,177,706 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Via Science's Form D filed Mar 4, 2025.
AJ
Adam Jackson
Director
AP
Alan Parnass
Director
DC
Danny Cotter
Director
KS
Kasper Sage
Director
CG
Colin Gounden
CEO and director
KR
Katherine Ravanis
Executive officer
Earlier filings also listed Duncan McFarland (director, last listed Feb 2022), Jeremy Taylor (chief scientific officer, last listed Apr 2020), Kristen Merrill (vice president, last listed Jun 2019) and Chris Daher (director of data science and technology, last listed Mar 2019).